GoodRx Holdings, Inc. Stock

Equities

GDRX

US38246G1085

Internet Services

Market Closed - Nasdaq 04:00:00 2024-06-24 pm EDT 5-day change 1st Jan Change
7.62 USD -1.42% Intraday chart for GoodRx Holdings, Inc. -9.18% +13.73%
Sales 2024 * 807M Sales 2025 * 884M Capitalization 2.86B
Net income 2024 * 41M Net income 2025 * 87M EV / Sales 2024 * 3.62 x
Net Debt 2024 * 62.11M Net cash position 2025 * 248M EV / Sales 2025 * 2.95 x
P/E ratio 2024 *
74.1 x
P/E ratio 2025 *
35.9 x
Employees 694
Yield 2024 *
-
Yield 2025 *
-
Free-Float 21.03%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on GoodRx Holdings, Inc.

1 day-1.42%
1 week-9.18%
Current month-3.18%
1 month+6.72%
3 months+15.81%
6 months+18.69%
Current year+13.73%
More quotes
1 week
7.59
Extreme 7.5901
8.18
1 month
7.06
Extreme 7.0601
9.06
Current year
5.27
Extreme 5.27
9.06
1 year
4.14
Extreme 4.135
9.37
3 years
3.82
Extreme 3.8201
48.05
5 years
3.82
Extreme 3.8201
64.22
10 years
3.82
Extreme 3.8201
64.22
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 23-04-24
Founder 46 11-08-31
Founder 53 11-08-31
Members of the board TitleAgeSince
Director/Board Member 59 16-05-31
Director/Board Member 54 15-09-30
Director/Board Member 49 18-09-30
More insiders
Date Price Change Volume
24-06-24 7.62 -1.42% 740,404
24-06-21 7.73 -0.90% 1,287,177
24-06-20 7.8 -4.41% 1,146,045
24-06-18 8.16 -2.74% 1,334,682

Delayed Quote Nasdaq, June 24, 2024 at 04:00 pm EDT

More quotes
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
7.62 USD
Average target price
9.513 USD
Spread / Average Target
+24.84%
Consensus